From gut to brain: NUS scientists engineer bacteria to treat severe liver-related brain dysfunction

In vivo studies showed that programmable "living medicines" could reduce brain toxins and prevent neurological symptoms of hepatic encephalopathy, offering distinct advantages over a widely prescribed antibiotic. SINGAPORE, April 28, 2026 /PRNewswire/ -- When the liver fails, toxins –...